MLKL-IN-2
MLKL-IN-2 is a MLKL inhibitor extracted from patent WO2021224505A1, compound (i) [1].
Product Specifications
CAS Number
899759-16-1
UNSPSC
12352005
Target
Mixed Lineage Kinase
Type
Reference compound
Related Pathways
MAPK/ERK Pathway
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/mlkl-in-2.html
Purity
99.45
Solubility
DMSO : 10 mg/mL (ultrasonic; warming; heat to 60°C)
Smiles
O=C(C1=CC=C2C=CC=CC2=C1)NC3=CC=CC(C4=NN=C(N5CCN(C)CC5)C=C4)=C3
Molecular Formula
C26H25N5O
Molecular Weight
423.51
References & Citations
[1]Sáez AJG, et, al. Modulation of mixed lineage kinase domain-like protein signaling. WO2021224505A1.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC681897-100 1x 100 µL
Caldesmon, HMW (h-Caldesmon) (Smooth Muscle Marker) (rCALD1/820), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
